Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

The contribution of combined imaging based on volumetric parameters with Ga-68 DOTA-TATE and F-18 FDG PET/CT in neuroendocrine tumors; comperative study with tumor proliferation indexes and serum chromogranin-A levels

Ummuhan Abdulrezzak
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1185;
Ummuhan Abdulrezzak
1Department of Nuclear Medicine, Erciyes University, School of Medicine, Kayseri, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 56 no. supplement 3 1185

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2015.

Copyright & Usage 

Author Information

  1. Ummuhan Abdulrezzak1
  1. 1Department of Nuclear Medicine, Erciyes University, School of Medicine, Kayseri, Turkey

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2015 to December 2022

AbstractFullPdf
May 20151100
Jun 20151700
Jul 20152400
Aug 2015200
Sep 20151100
Oct 20152500
Nov 20151000
Dec 2015100
Jan 20161900
Feb 2016900
Mar 20161800
Apr 2016200
May 2016600
Jun 2016600
Jul 2016500
Aug 2016100
Sep 2016400
Oct 2016200
Nov 2016500
Dec 2016400
Jan 2017600
Feb 2017400
Mar 2017500
Apr 2017100
May 2017600
Jun 2017200
Aug 2017200
Sep 2017500
Oct 2017600
Nov 2017100
Jan 2018200
Mar 2018200
Apr 2018200
May 2018200
Jun 2018300
Sep 2018100
Oct 2018100
Nov 2018100
Dec 2018500
Feb 2019200
Mar 2019500
Apr 2019200
Jun 2019200
Aug 2019100
Sep 2019300
Oct 2019300
Dec 2019100
Jan 2020200
Feb 2020100
Mar 2020200
Apr 2020200
May 2020100
Aug 2020200
Dec 2020100
Jan 2021100
Feb 2021800
Mar 2021800
Apr 2021700
May 2021800
Jun 2021400
Jul 2021100
Aug 2021200
Sep 2021300
Oct 2021100
Nov 2021100
Dec 2021200
Jan 2022300
Feb 2022700
Mar 2022300
Apr 2022100
May 2022200
Jun 2022100
Aug 2022100
Dec 2022200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The contribution of combined imaging based on volumetric parameters with Ga-68 DOTA-TATE and F-18 FDG PET/CT in neuroendocrine tumors; comperative study with tumor proliferation indexes and serum chromogranin-A levels
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The contribution of combined imaging based on volumetric parameters with Ga-68 DOTA-TATE and F-18 FDG PET/CT in neuroendocrine tumors; comperative study with tumor proliferation indexes and serum chromogranin-A levels
Ummuhan Abdulrezzak
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1185;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The contribution of combined imaging based on volumetric parameters with Ga-68 DOTA-TATE and F-18 FDG PET/CT in neuroendocrine tumors; comperative study with tumor proliferation indexes and serum chromogranin-A levels
Ummuhan Abdulrezzak
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1185;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Analysis of the 131I therapy in the young and adolescent patients with differentiated thyroid carcinoma
  • Volume changes in functional volumes of absorbed dose calculation to the kidneys and spleen in patients with neuroendocrine tumours receiving 177Lu-Octreotate therapy
  • Optimizing and Validating Reduced PET Volume Overlap in 18F-FDG Oncology Wholebody PET/CT to Improve Speed and Patient Comfort
Show more Oncology: Basic, Translational & Therapy

MTA I: Basic Science Posters

  • In Vivo PET/CT neuroimaging of radiolabeled nanocarriers following intranasal drug delivery (INDD): Validation using Ex Vivo PET/CT, gamma counting and autoradiography.
  • 18F-ML10 PET/CT demonstrates therapy-induced apoptosis in murine pancreatic adenocarcinoma
  • Exploiting the DNA damage response to improve peptide receptor radionuclide therapy outcome
Show more MTA I: Basic Science Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire